Literature DB >> 3790964

Management of acute cholangitis and the impact of endoscopic sphincterotomy.

T Leese, J P Neoptolemos, A R Baker, D L Carr-Locke.   

Abstract

Ninety-four patients admitted to Leicester Hospitals with acute cholangitis since 1977 were reviewed to coincide with the availability of endoscopic sphincterotomy (ES). Thirty-four were men and sixty were women, their mean age was 69.7 years and the median hospital stay was 20 days. There were 15 deaths (16 per cent) by 30 days in patients with significantly lower initial serum albumin levels (P less than 0.005) and significantly higher serum urea levels (P less than 0.05) than survivors. Eighty-two patients had common bile duct (CBD) calculi of whom 71 underwent early decompression of the biliary tree either surgically (28) or by ES(43). Early surgical decompression was associated with a significantly higher 30 day mortality (6/28) than early ES (2/43) (P less than 0.02) despite the fact that patients undergoing early ES were significantly older (P less than 0.02) and had significantly more medical risk factors (P less than 0.05). Of the 43 patients undergoing early ES 7 had had a previous cholecystectomy, 13 underwent subsequent elective cholecystectomy with no mortality and the remaining 23 had the gallbladder left in situ because of advanced age (mean age 79 years) and frailty. Only 2 of the 23 have since required cholecystectomy. We suggest that patients with acute cholangitis who do not rapidly respond to conservative treatment should undergo early ES with early surgery reserved for those who do not improve following ES. Elective cholecystectomy following successful ES can often be avoided in the elderly and frail.

Entities:  

Mesh:

Year:  1986        PMID: 3790964     DOI: 10.1002/bjs.1800731214

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  34 in total

Review 1.  Endoscopic removal of common duct stones: current indications and controversies.

Authors:  R C Horton; A Lauri; J S Dooley
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 2.  Endoscopic management of biliary tract stones and stenosis.

Authors:  D S Zimmon; A R Clemett
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Aug-Sep       Impact factor: 2.740

3.  Choledocholithiasis. Endoscopic sphincterotomy or common bile duct exploration.

Authors:  S C Stain; H Cohen; M Tsuishoysha; A J Donovan
Journal:  Ann Surg       Date:  1991-06       Impact factor: 12.969

4.  Factors affecting morbidity and mortality in biliary tract surgery.

Authors:  C H Su; F K P'eng; W Y Lui
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

5.  Emergency surgery for severe acute cholangitis. The high-risk patients.

Authors:  E C Lai; P C Tam; I A Paterson; M M Ng; S T Fan; T K Choi; J Wong
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

6.  Changing methods of imaging the common bile duct in the laparoscopic cholecystectomy era in Western Australia: implications for surgical practice.

Authors:  Nigel T Barwood; Liora J Valinsky; Michael S T Hobbs; David R Fletcher; Matthew W Knuiman; Steve C Ridout
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

7.  Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis.

Authors:  B C Sharma; N Agarwal; P Sharma; S K Sarin
Journal:  Dig Dis Sci       Date:  2008-09-19       Impact factor: 3.199

8.  Retained common bile duct stones after endoscopic sphincterotomy: temporary and longterm treatment with biliary stenting.

Authors:  D G Maxton; D E Tweedle; D F Martin
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  Gallstone cholangitis: a 10-year experience of combined endoscopic and laparoscopic treatment.

Authors:  L Sarli; D Iusco; G Sgobba; L Roncoroni
Journal:  Surg Endosc       Date:  2002-03-05       Impact factor: 4.584

10.  Endoscopic management of acute cholangitis in elderly patients.

Authors:  Naresh Agarwal; Barjesh Chander Sharma; Shiv K Sarin
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.